Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Tables)

6 Months Ended

May 31, 2023

As of May 31, 2023 and November 30, 2022, the note payable obligation was as follows:


	May 31, 2023			November 30, 2022
Note payable - Susser	$	8,844,310		$	8,921,437
Unamortized debt issuance costs - Susser		(180,172	)		(191,035	)
Net note payable	$	8,664,138		$	8,730,402
Current portion of note payable	$	158,456		$	150,527
Long-term note payable, net of debt issuance costs		8,505,682			8,579,875
Total	$	8,664,138		$	8,730,402

Interest expense on the note payable for the three and six months ended May 31, 2023 and 2022 was as follows:


	For the three months ended		For the six months ended
	May 31, 2023		May 31, 2023
Interest expense on notes payable - Susser	$	204,206	$	406,681
Debt issuance costs - Susser		5,418		10,862
Total interest expense	$	209,624	$	417,543


	For the three months ended		For the six months ended
	May 31, 2022		May 31, 2022
Interest expense on notes payable - TCB	$	5,969	$	18,115
Debt issuance costs - TCB		3,388		9,777
Total interest expense	$	9,357	$	27,892